1
TITLE: Clinical activity of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in HER2 amplified metastatic breast cancer (MBC) patients (pts) who had progressed on anti-HER2 ADCs.
AUTHORS: Erika Paige Hamilton; Thierry Petit; Barbara Pistilli; Anthony Goncalves; Ana Alexandra Ferreira; Florence Dalenc; Fatima Cardoso; Monica M Mita; Vincent O Dezentj; Luis Manso; Stephanie L Graff; Francois Clement Bidard; Philippe Georges Aftimos; Santiago Escriv; Noemia Afonso; Ernesto Wasserman; Kees Bol; Viktoriya Stalbovskaya; Anastasia Vliet; Thomas Bachelot;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
INDEXED IN: WOS